Related Experiment Video
Updated: May 26, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
[Postpartum haemorrhage and factor VII deficiency]
H Harkouk1, F Chakib Rahmoune, D Benhamou
1Service d'anesthésie-réanimation, hôpital Bicêtre, AP-HP, 94275 Le Kremlin-Bicêtre cedex, France.
Severe postpartum hemorrhage occurred in a patient with congenital factor VII deficiency. This case highlights the critical bleeding risks and management strategies for factor VII deficiency during pregnancy and postpartum.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Anesthesiology
Background:
- Pregnancy normally elevates plasma factor VII concentrations, potentially masking underlying deficiencies.
- Congenital factor VII deficiency is a rare inherited bleeding disorder.
- Factor VII is a crucial clotting factor essential for hemostasis.
Observation:
- A patient with undiagnosed congenital factor VII deficiency experienced severe postpartum hemorrhage.
- The hemorrhage necessitated aggressive resuscitation with blood transfusions and surgical intervention.
- Physiological changes during pregnancy can alter the presentation of bleeding disorders.
Findings:
- Congenital factor VII deficiency poses a significant hemorrhagic risk, particularly postpartum.
- Prompt diagnosis and multidisciplinary management are vital for patient outcomes.
- Factor VII levels can be critically low in affected individuals, impairing coagulation.
Implications:
- This case underscores the importance of considering rare bleeding disorders in obstetric emergencies.
- Optimal anesthetic management is crucial for patients with factor VII deficiency undergoing surgery.
- Further research into managing factor VII deficiency in pregnancy is warranted to improve patient safety.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
